Evidence map›Paper›PMID 31781845›Full record

ReviewVirchows Archiv : an international journal of pathology2020

The clinico-pathological spectrum of primary cutaneous lymphoma other than mycosis fungoides/Sezary syndrome.

Ilske Oschlies, Rebecca L King, Snjezana Dotlic, Santiago Montes-Moreno, Maurilio Ponzoni, Alexandra Traverse-Glehen, Maria Calaminici, Judith A Ferry, German Ott, John R Goodlad

Abstract readReview
PubMed Publisher
In one paragraph

Review in Virchows Archiv : an international journal of pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Recent advances in cutaneous lymphoma-implications for current and future classifications.Virchows Archiv : an international journal of pathology · 2023
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 7 countries.

Ilske OschliesDepartment of Pathology, Hematopathology Section and Lymph Node Registry, University Hospitals Schleswig-Holstein, Christian-Albrecht-University, Kiel, Germany.
Rebecca L KingDivision of Hematopathology, Mayo Clinic, Rochester, MN, USA.
Snjezana DotlicDepartment of Pathology and Cytology, University Hospital Centre Zagreb, Zagreb, Croatia.
Santiago Montes-MorenoDepartment of Anatomic Pathology, Translational Hematopathology Lab, Hospital Universitario Marques de Valdecilla/IDIVAL, Santander, Spain.
Maurilio PonzoniAteneo Vita-Salute San Raffaele and Unit of Lymphoid Malignancies, San Raffaele Scientific Institute, Milan, Italy.
Alexandra Traverse-GlehenDepartment of Hematopathology, Hospices Civils de Lyon/Université Lyon 1, Lyon, France.
Maria CalaminiciDepartment of Cellular Pathology, SIHMDS, Barts Health NHS Trust and Centre for Haemato-Oncology, Barts Cancer Institute, London, UK.
Judith A FerryDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
German OttDepartment of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany.
John R GoodladDepartment of Pathology, Queen Elizabeth University Hospital, Level 3, Laboratory Medicine Building, 1345 Govan Rd, Glasgow, G51 4TF, Scotland. john.goodlad@nhs.net.ORCID http://orcid.org/0000-0002-8385-8517
Barts Health NHS Trust · GBHarvard University · USInstituto de Investigación Marqués de Valdecilla · ESMayo Clinic in Arizona · USQueen Elizabeth University Hospital · GBRobert Bosch Hospital · DEUniversité Claude Bernard Lyon 1 · FRUniversity Hospital Centre Zagreb · HRVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The major aim of Session 1 of the 2018 European Association of Hematopathology/Society for Hematopathology Workshop was to collect examples of cutaneous lymphomas, excluding mycosis fungoides/Sezary syndrome, as defined in the current WHO classification of tumours of the haemetopoietic and lymphoid tissues. Overall 42 cases were submitted. These were considered in four main categories: primary cutaneous B cell lymphomas (12 cases), primary cutaneous T cell lymphomas/lymphoproliferations with CD8+/cytotoxic phenotype (12 cases), primary cutaneous CD30-positive lymphoproliferative disorders (15 cases) and primary cutaneous T cell lymphomas/leukaemias with CD4+ phenotype (4 cases). Using these cases as examples, we were able to present the full spectrum of cutaneous lymphoproliferations (excluding mycosis fungoides/Sezary syndrome), including examples of rare, provisional and new entities as listed in the 2017 update of the WHO classification. The findings are summarized in this report with emphasis on differential diagnostic considerations and the importance of clinico-pathological correlation for final subtyping. In presenting these findings we hope to raise awareness of this enigmatic group of neoplasms and to further our understanding of these rare disease entities.

Indexed as

HumansLeukemiaLymphoma, B-CellLymphoma, T-Cell, CutaneousLymphoproliferative DisordersSkin NeoplasmsCutaneous lymphomasPrimary cutaneous B cell lymphomaPrimary cutaneous CD30-positive lymphoproliferative disorderPrimary cutaneous CD8-positive lymphomasPrimary cutaneous T cell lymphomas

Identifiers

PMID31781845
OpenAlexW2990012259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.